Clinical Efficacy Of Misight 1 Day® Soft Contact Lenses In Myopic Children
Published 2023 - 41st Congress of the ESCRS
Reference: PO1016 | Type: Free paper | DOI: 10.82333/0cc4-ng49
Authors: Hui Kyung Kim* 1 , Myung Ho Cho 1 , Yeon Ji Jo 1 , Jong Soll Lee 1
1Pusan national university,Pusan,Korea, Republic Of
Purpose
The aim of this study is to evaluate the clinical outcomes of dual-focus contact lens (MiSight 1 day®, Cooper vision) designed to control myopia progression on children.
Setting
The refractive changes, astigmatism, and visual acuity before and after MiSight 1 day® lens use were investigated in 131 eyes of 66 children.
Methods
For evaluating the comparison of myopic progression between two groups; Group A was 55 eyes who had previously used Ortho-K lens, and then applied to MiSight 1 day® lens consequently, Group B was 76 eyes used MiSight 1 day® lens initially.
Results
The average age of 66 patients was 10.9±2.3 years, from 5 to 16 years, and the follow-up period was 6.6±3.7 months. The average refractive error before MiSight 1 day® lens use was 3.64±1.56 (D), and the average refractive error at the final visit was 3.65±1.57 (D). There were no significant changes of refractive error in 129 eyes, and the effect of MiSight 1 day® lens to suppress myopia progression was excellent at 98.5%. In comparison of two groups, the efficacy of visual acuity with MiSight 1 day® lens 0.93±0.13 logMAR in group A and 0.95±0.09 logMAR in group B. There were also no significant changes of refractive error by MiSight 1 day® lens with and without Ortho-K lens (t-test, p>0.05).
Conclusions
MiSight 1 day® lens has effectively prevent from the progression of myopia in children and are expected to be widely used due to high quality of outcomes for prevention of progress myopia.